NanoSphere Health Sciences Inc. (NSHS)
CSE
Closed
Sep 21, 2026
Day's Range
0.020052 wk Range
0.0200Overview - NSHS - NanoSphere Health Sciences Inc.
Key Statistics
Valuation
Enterprise Value
388.47K
P/E (Trailing)
‪0.50‬
EV / EBITDA
‪-2.17‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-503.30%‬
Return on Equity
‪6.27%‬
Ownership
Shares Outstanding
10.27M
Float
6.53M
Held by Insiders
‪32.28%‬
Held by Institutions
‪0.00%‬
Price stats
50-Day Avg
‪0.0212‬
200-Day Avg
‪0.0229‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - NSHS - NanoSphere Health Sciences Inc.
Peers - NSHS - NanoSphere Health Sciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on CSE.
- NSHSCSENanoSphere Health Sciences Inc.205.50KMarket Cap-25.00%52-week change0.50P/E (Trailing)‪0.00%‬Profit Margin
- BETRCSEBetterLife Pharma Inc.57.83MMarket Cap+75.00%52-week change-34.00P/E (Trailing)‪0.00%‬Profit Margin
- BLABCSEBritannia Life Sciences Inc.11.52MMarket Cap+7.14%52-week change0.70P/E (Trailing)‪4,069.60%‬Profit Margin
- BOBOLTCSEBolt Metals Corp.9.28MMarket Cap-53.21%52-week change-0.27P/E (Trailing)‪0.00%‬Profit Margin
- BIOVCSEBioVaxys Technology Corp.2.84MMarket Cap-264.29%52-week change-0.35P/E (Trailing)‪0.00%‬Profit Margin
- ASEPCSEAsep Medical Holdings Inc.1.58MMarket Cap-400.00%52-week change-0.21P/E (Trailing)‪97.18%‬Profit Margin
- BRAXCSEBraxia Scientific Corp.1.41MMarket Cap+0.00%52-week change-0.08P/E (Trailing)‪9.11%‬Profit Margin
Profile Summary - NSHS - NanoSphere Health Sciences Inc.
About
NanoSphere Health Sciences Inc. is a nano-biotechnology company specializing in advanced delivery systems for biologically active compounds. The firm’s primary focus is on its patented NanoSphere Delivery System, a platform that uses nanotechnology to improve the bioavailability and absorption of cannabinoids,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
